Tag: Batten
The State of Bitcoin Mining with Daniel Batten
We were able to collect the expertise of Daniel Battenduring an exclusive one-hour conference on Bitcoin mining. Daniel Batten is the co-founder of CH4 Capital which aims to eliminate methane…
Theranexus on the rise after positive results against Batten disease – 09/29/2023 at 09:42
(AOF) – Theranexus (+11.49% to 1.30 euros) is up sharply after announcing “very encouraging” intermediate results of effectiveness and tolerance after 12 months of treatment in the phase 1 study/…
Theranexus: promising results in Batten disease – 09/29/2023 at 11:31
(CercleFinance.com) – Theranexus recorded a sharp increase on Friday on the Paris Stock Exchange following the presentation of interim results considered ‘very encouraging’ in the treatment of Batten disease. At…
THERANEXUS: Encouraging preliminary results at 6 months in the phase 1/2 study of Batten-1 in Batten disease (CLN3) – 06/14/2023 at 07:30
Reduction after 6 months of treatment of neurofilaments, a biomarker of neuronal death Stabilization of motor symptoms for treated patients compared to an expected deterioration according to the natural history…
Theranexus up after EMA approval for Batten disease study – 06/07/2023 at 11:02
(AOF) – Theranexus is up 8.65% to 1.85 euros after announcing with the Beyond Batten Disease Foundation (BBDF) that it has obtained the positive opinion of the European Medicines Agency…
THERANEXUS: New progress for the Batten-1 Program of Theranexus and the BBDF foundation in the juvenile form of Batten disease (CLN3) – 01/05/2023 at 18:00
Lyon, France – Austin, Texas, United States – January 5, 2023 – 6:00 p.m. CET – Theranexus, an innovative biopharmaceutical company in the treatment of neurological diseases and a pioneer…
THERANEXUS: Theranexus and the BBDF foundation finalize the recruitment of the phase I/II study evaluating Batten-1 in Batten disease – 09/08/2022 at 18:00
Lyon, France – Austin, Texas, United States – September 8, 2022 – 6:00 p.m. CEST – Theranexus, an innovative biopharmaceutical company in the treatment of neurological diseases and a pioneer…